Nav: Home

Report: Cancer remains leading cause of death in US Hispanics

September 16, 2015

ATLANTA -September 16, 2015- While cancer is the second leading cause of death overall in the United States, it remains the leading cause of death among U.S. Hispanics. The finding comes from "Cancer Statistics for Hispanics/Latinos," a comprehensive report produced every three years by the American Cancer Society and published in CA: A Cancer Journal for Clinicians.

Hispanics/Latinos represent the largest racial/ethnic minority group in the United States, accounting for 17.4% of the total U.S. population in 2014. In 2015, 125,900 new cancer cases and 37,800 cancer deaths are expected among Hispanics/Latinos in the U.S.

Lung cancer remains the leading cause of cancer death for Hispanic men, accounting for about one in six cancer deaths (17%). Based on the 2015 estimates, liver cancer is projected to surpass colorectal cancer as the second leading cause of cancer deaths among Hispanic men. Liver cancer incidence and death rates in Hispanic men and women are about double those in non-Hispanic whites.

Among Hispanic women, the leading cause of cancer death is breast cancer (16%), followed by lung and colorectal cancers. Lung cancer surpassed breast cancer as the leading cause of death among women overall in the U.S. in 1987. Lung cancer death rates in Hispanic women are 70% lower than those in non-Hispanic white women because of historically low smoking prevalence in Hispanic women. In 2014, 8% of Hispanic women smoked cigarettes compared to 17% of non-Hispanic white women.

Cancer death rates have been decreasing since 1995 in Hispanic men and since 1996 in Hispanic women, four years later than declines began in non-Hispanic whites. Cancer incidence rates among Hispanics/Latinos are dropping 2.4% per year in men and 0.5% per year in women, mirroring trends among non-Hispanic whites.

Overall, cancer incidence rates are 20% lower in Hispanics than in non-Hispanic whites and cancer death rates are 30% lower. This is mainly because Hispanics are less likely than non-Hispanic whites to be diagnosed with the four most common cancers (prostate, breast, lung, and colon). However, Hispanics have a higher risk of cancers associated with infectious agents, such as those of the stomach, liver, and cervix. For example, stomach and liver cancer incidence and death rates in Hispanics are double those in non-Hispanic whites.

The cancer profile of Hispanics/Latinos living in the U.S. is strikingly different from that for non-Hispanic whites and reflects the risk in countries of origin, particularly for more recent immigrants. For example, overall, death and incidence rates in Puerto Ricans and Cubans are more similar to those in non-Hispanic whites than in those of Mexican origin, who immigrated to the U.S. in large numbers more recently.

Hispanics are particularly vulnerable to cancer inequalities. They are generally less likely than non-Hispanic whites to be diagnosed at an early stage, especially for melanoma and female breast cancer. Although less access to high-quality care due to lower socioeconomic status contributes to this disparity, some studies have shown that Hispanics are at higher risk of advanced-stage disease even when socioeconomic status and health care access are similar.

"The growth in the population of U.S. residents of Hispanic origin is now driven primarily by births, not immigration, which will probably change the future cancer risk profile of this group" said Rebecca L. Siegel, MPH, director of surveillance information for the American Cancer Society and lead author of the report. "The second generation, born and raised in the U.S. and more intertwined in our lifestyle, including our diet, has higher cancer rates than first-generation immigrants, so we may see a higher cancer burden in this group in the future."

The authors say progress in cancer control in Hispanics/Latinos should include the use of culturally appropriate lay health advisors and patient navigators; targeted, community-based intervention programs to increase screening and vaccination and encourage healthy lifestyle behaviors; and further funding for research into cancer risk and prevention among specific subgroups in this population.
-end-
Article: Cancer Statistics for Hispanics/Latinos, 2015, CA Cancer J Clin 2015; doi: 10.3322/caac.21314

Authors are: Rebecca L. Siegel, MPH; Stacey A. Fedewa, MPH; Kimberly D. Miller, MPH; Ann Goding-Sauer, MPH; and Ahmedin Jemal, DVM, PhD, American Cancer Society; Paulo S. Pinheiro, MD, University of Nevada, Las Vegas, PhD; and Dinorah Martinez-Tyson, PhD, MPH, MA, University of South Florida.

American Cancer Society

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.